Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma

被引:0
|
作者
Bao-Min Shi [1 ]
Wen Lu [2 ]
Kun Ji [1 ]
Yu-Feng Wang [1 ]
Shuai Xiao [1 ]
Xiu-Yan Wang [2 ]
机构
[1] Department of General Surgery,Tongji Hospital,Medical School of Tongji University
[2] Department of Ultrasound,Tongji Hospital,Medical School of Tongji University
关键词
Mi R-106b; Hepatocellular carcinoma; ROC curve; Random sampling survey;
D O I
暂无
中图分类号
R735.7 [肝肿瘤];
学科分类号
100214 ;
摘要
AIM To investigate the short-term outcomes and risk factors indicating postoperative death of patients with lesions adjacent to the hepatocaval confluence.METHODS We retrospectively analyzed 54 consecutive patients who underwent hepatectomy combined with inferior vena cava(IVC)and/or hepatic vein reconstruction(HVR)from January 2012 to January 2016 at our liver surgery center.The patients were divided into5 groups according to the range of IVC and hepatic vein involvement.The patient details,indications for surgery,operative techniques,intra-and postoperative outcomes were compared among the 5 groups.Univariate and multivariate analyses were performed to explore factors predictive of overall operative death.RESULTS IVC replacement was carried out in 37(68.5%)patients and HVR in 17(31.5%)patients.Type I2H2 had the longest operative blood loss,operative duration and overall liver ischemic time(all,p<0.05).Three patients of Type I3H1 with totally occluded IVC did not need IVC reconstruction.Total postoperative morbidity rate was40.7%(22 patients)and the operative mortality rate was 16.7%(9 patients).Factors predictive of operative death included IVC replacement(p=0.048),duration of liver ischemia(p=0.005)and preoperative liver function being Child-pugh B(p=0.025). CONCLUSION IVC replacement,duration of liver ischemia and preoperative poor liver function were risk factors predictive of postoperative death.We should be cautious about IVC replacement,especially in Type I2H2.For Type I3H1,it was unnecessary to replace IVC when the collateral circulation was established.
引用
收藏
页码:3713 / 3720
页数:8
相关论文
共 50 条
  • [1] Study on the value of serum miR-106b for the early diagnosis of hepatocellular carcinoma
    Shi, Bao-Min
    Lu, Wen
    Ji, Kun
    Wang, Yu-Feng
    Xiao, Shuai
    Wang, Xiu-Yan
    WORLD JOURNAL OF GASTROENTEROLOGY, 2017, 23 (20) : 3713 - 3720
  • [2] MiR-106b mediates sorafenib refractory hepatocellular carcinoma progression
    Wang, W.
    Su, Z.
    Hsieh, W.
    Yen, C.
    FEBS OPEN BIO, 2018, 8 : 310 - 310
  • [3] miR-106b promotes cancer progression in hepatitis B virusassociated hepatocellular carcinoma
    Chia-Sheng Yen
    Zhi-Ru Su
    Yi-Ping Lee
    I-Ting Liu
    Chia-Jui Yen
    World Journal of Gastroenterology, 2016, 22 (22) : 5183 - 5192
  • [4] miR-106b promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma
    Yen, Chia-Sheng
    Su, Zhi-Ru
    Lee, Yi-Ping
    Liu, I-Ting
    Yen, Chia-Jui
    WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (22) : 5183 - 5192
  • [5] Usefulness of serum miR-1246/miR-106b ratio in patients with esophageal squamous cell carcinoma
    Hoshino, Isamu
    Ishige, Fumitaka
    Iwatate, Yosuke
    Gunji, Hisashi
    Shiratori, Fumiaki
    Kuwayama, Naoki
    Nabeya, Yoshihiro
    Takeshita, Nobuyoshi
    Matsubara, Hisahiro
    ONCOLOGY LETTERS, 2020, 20 (06)
  • [6] miR-106b downregulates adenomatous polyposis coli and promotes cell proliferation in human hepatocellular carcinoma
    Shen, Gang
    Jia, Hongyun
    Tai, Qiang
    Li, Yanhao
    Chen, Deji
    CARCINOGENESIS, 2013, 34 (01) : 211 - 219
  • [7] miR-106b targets DAB2 to promote hepatocellular carcinoma cell proliferation and metastasis
    Sun, Chunhui
    Yao, Xun
    Jiang, Qingyu
    Sun, Xiuyong
    ONCOLOGY LETTERS, 2018, 16 (03) : 3063 - 3069
  • [8] Downregulation of serum miR-106b: a potential biomarker for Alzheimer disease
    Madadi, Soheil
    Saidijam, Massoud
    Yavari, Bahram
    Soleimani, Meysam
    ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY, 2022, 128 (04) : 875 - 879
  • [9] Prognostic value of miR-106b expression in breast cancer patients
    Zheng, Ruohui
    Pan, Lingxiao
    Gao, Jin
    Ye, Xigang
    Chen, Lun
    Zhang, Xiaoshen
    Tang, Wei
    Zheng, Wenbo
    JOURNAL OF SURGICAL RESEARCH, 2015, 195 (01) : 158 - 165
  • [10] Over-expression of miR-106b in metastatic hepatocellular carcinoma using an orthotopic metastasis animal model
    Yau, Wing Lung
    Pang, Roberta Wen Chi
    Lee, Terence Kin Wah
    Wo, Jana Yim Hung
    Poon, Ronnie Tung Ping
    CANCER RESEARCH, 2010, 70